Federal regulators have abandoned a plan that physicians, patients, and advocacy groups for breast cancer patients feared would limit women’s options for reconstructive surgery.
Pharmalittle: We’re reading about menopause treatments, Novo plans for Wegovy in India, and more
Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting over the Pharmalot campus, where
December 3, 2024